“A Case Report Overwhelming Response to TNF-Alfa Inhibitor Infliximab “innovator” Vs. Adalimumab ‘Bio-similar’ in a Previously Therapy Naive Adult”. Indian Journal of Case Reports, vol. 8, no. 3, Mar. 2022, pp. 58-61, https://doi.org/10.32677/ijcr.v8i3.3317.